Barriers to Genetic Testing in Newly Diagnosed Breast Cancer Patients: Where Can We Improve?

被引：0
|
作者：
Hafertepen, Laura [1 ]
Pastorino, Alyssa [2 ]
Mormon, Nichole [3 ]
Halaharvi, Deepa [3 ]
Byrne, Lindsey [3 ]
Cripe, Mark [3 ]
机构：
[1] OhioHealth, Grant Med Ctr, Columbus, OH USA
[2] OhioHealth, Doctors Hosp, Columbus, OH USA
[3] OhioHealth, Columbus, OH USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2016年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0371
引用
收藏
页码：78 / 79
页数：2
相关论文
共 50 条
  • [21] Lung Cancer Screening: Where Are We, and How Can We Improve?
    Suzuki, Kei
    Ceppa, DuyKhanh P.
    THORACIC SURGERY CLINICS, 2023, 33 (04) : XIII - XIV
  • [22] Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: Where are we today?
    Cole, DEC
    Gallinger, S
    McCready, DR
    Rosen, B
    Engel, J
    Malkin, D
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1996, 154 (02) : 149 - 155
  • [23] Universal genetic testing for women with newly diagnosed breast cancer in the context of multidisciplinary team care
    De Silva, Dilanka L.
    Stafford, Lesley
    Skandarajah, Anita R.
    Sinclair, Michelle
    Devereux, Lisa
    Hogg, Kirsten
    Kentwell, Maira
    Park, Allan
    Lal, Luxi
    Zethoven, Magnus
    Jayawardana, Madawa W.
    Chan, Fiona
    Butow, Phyllis N.
    James, Paul A.
    Mann, G. Bruce
    Campbell, Ian G.
    Lindeman, Geoffrey J.
    MEDICAL JOURNAL OF AUSTRALIA, 2023, 218 (08) : 368 - 373
  • [24] Utility of expedited hereditary cancer testing in surgical management of newly diagnosed breast cancer patients
    Theobald, Kristin
    Susswein, Lisa
    Roberts, Maegan
    Marshall, Megan
    Mester, Jessica
    Speyer, Darrow
    Williams, Ravin
    Knapke, Sara
    Murphy, Patricia
    Klein, Rachel
    Hruska, Kathleen
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : 266 - 267
  • [25] Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
    Moschetta, Michele
    Boussios, Stergios
    Rassy, Elie
    Samartzis, Eleftherios P.
    Funingana, Gabriel
    Uccello, Mario
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)
  • [26] How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?
    Harputluoglu, H.
    Altundag, K.
    ANNALS OF ONCOLOGY, 2008, 19 (06) : 1203 - 1203
  • [27] Consensus Resuscitation Plan Documentation in Patients With Metastatic Cancer - Where are We and How Can We Improve?
    Gard, Grace
    McMorrow, Rita
    Con, Danny
    Bredin, Phillip
    Parente, Phillip
    Wong, Rachel
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 178 - 178
  • [28] Consensus Resuscitation Plan Documentation in Patients with Metastatic Cancer - Where are we and how can we Improve?
    Gard, G.
    Con, D.
    McMorrow, R.
    Bredin, P.
    Parente, P.
    Wong, R.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 60 - 60
  • [29] Role of Breast MRI in Patients with Newly Diagnosed Breast Cancer
    L. Albert M.
    Gao Y.
    Moy L.
    Current Breast Cancer Reports, 2016, 8 (2) : 80 - 89
  • [30] Surgical decisions of newly diagnosed breast cancer patients following genetic referral.
    McAlister, Jennifer
    Dekhne, Nayana
    Yadav, Siddhartha
    Zakalik, Dana
    Lowry, Heather
    DeLaere, Angela
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
12345